Constar Grants Oxbar(R) License to PAGO International
05 Juin 2006 - 2:00PM
Business Wire
Constar International Inc. (NASDAQ: CNST) has entered into an
Oxbar(R) patent license agreement with Pago International of
Austria under which Pago will be able to market its juice and
nectar products packaged in PET bottles with enhanced
oxygen-scavenger protection, for excellent retention of product
quality in retail distribution throughout Europe.
Philadelphia-based Constar International Inc. is a leading global
producer of PET (polyethylene terephthalate) plastic containers for
food, soft drinks and water. The company provides full service
packaging solutions, from product design and engineering to ongoing
customer support. Its customers include many of the world's largest
consumer product companies. Pago International GmbH is an
internationally operating premium fruit juice company. They are
market leader in five European countries with a commitment to the
highest standards for fruit juices as well as for their internal
processes, customer relations and employee's careers. For
additional information contact Alan Silverman, Vice President,
Marketing and Business Development, Constar International Inc.,
(215) 552-3700 Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all information in this press
release consists of forward-looking statements within the meaning
of the federal securities laws. These forward-looking statements
involve a number of risks, uncertainties and other factors, which
may cause the actual results to be materially different from those
expressed or implied in the forward-looking statements. Important
factors that could cause the statements made in this press release
or the actual results to differ are discussed under the caption
"Risk Factors" in Constar's Form 10-K Annual Report for the year
ended December 31, 2005 and in subsequent filings with the
Securities and Exchange Commission made prior to, on or after the
date hereof. Constar does not intend to review or revise any
particular forward-looking statement in light of future events.
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur Constar International Inc.